XBI Holdings — SPDR(R) S&P(R) Biotech ETF
All 158 reported holdings of SPDR(R) S&P(R) Biotech ETF (XBI) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| State Street Global Advisors | 8.01% | $595.46M |
| Apellis Pharmaceuticals Inc | 1.83% | $136.40M |
| Alkermes PLC | 1.45% | $107.88M |
| Madrigal Pharmaceuticals Inc | 1.38% | $102.81M |
| TG Therapeutics Inc | 1.35% | $100.33M |
| Insmed Inc | 1.34% | $99.39M |
| Scholar Rock Holding Corp | 1.30% | $96.45M |
| Apogee Therapeutics Inc | 1.28% | $95.48M |
| Protagonist Therapeutics Inc | 1.24% | $92.55M |
| Summit Therapeutics Inc | 1.24% | $92.27M |
| United Therapeutics Corp | 1.24% | $92.23M |
| Praxis Precision Medicines Inc | 1.24% | $91.91M |
| Arrowhead Pharmaceuticals Inc | 1.23% | $91.43M |
| Cogent Biosciences Inc | 1.22% | $90.38M |
| Bridgebio Pharma Inc | 1.19% | $88.13M |
| PTC Therapeutics Inc | 1.18% | $87.89M |
| Cytokinetics Inc | 1.18% | $87.76M |
| Alnylam Pharmaceuticals Inc | 1.18% | $87.48M |
| Exelixis Inc | 1.17% | $87.03M |
| Nuvalent Inc | 1.17% | $86.75M |
| Kymera Therapeutics Inc | 1.16% | $86.56M |
| CG oncology Inc | 1.16% | $86.42M |
| Natera Inc | 1.16% | $86.18M |
| Neurocrine Biosciences Inc | 1.16% | $86.16M |
| Twist Bioscience Corp | 1.16% | $85.92M |
| Krystal Biotech Inc | 1.15% | $85.83M |
| Vaxcyte Inc | 1.15% | $85.58M |
| Mirum Pharmaceuticals Inc | 1.15% | $85.31M |
| Amicus Therapeutics Inc | 1.15% | $85.25M |
| Ionis Pharmaceuticals Inc | 1.14% | $85.07M |
| Travere Therapeutics Inc | 1.14% | $85.07M |
| Arcellx Inc | 1.14% | $85.06M |
| Regeneron Pharmaceuticals Inc | 1.14% | $84.53M |
| Incyte Corp | 1.13% | $84.24M |
| Celcuity Inc | 1.12% | $83.54M |
| Revolution Medicines Inc | 1.11% | $82.74M |
| Halozyme Therapeutics Inc | 1.11% | $82.37M |
| Rhythm Pharmaceuticals Inc | 1.10% | $81.85M |
| Biogen Inc | 1.10% | $81.56M |
| Arcutis Biotherapeutics Inc | 1.09% | $80.99M |
| AbbVie Inc | 1.09% | $80.93M |
| Gilead Sciences Inc | 1.09% | $80.87M |
| CRISPR Therapeutics AG | 1.09% | $80.72M |
| BioMarin Pharmaceutical Inc | 1.07% | $79.35M |
| Roivant Sciences Ltd | 1.07% | $79.34M |
| Amgen Inc | 1.06% | $79.01M |
| ImmunityBio Inc | 1.06% | $78.57M |
| Beam Therapeutics Inc | 1.04% | $77.41M |
| Viking Therapeutics Inc | 1.04% | $77.09M |
| Vera Therapeutics Inc | 1.03% | $76.92M |
| Moderna Inc | 1.03% | $76.90M |
| Vertex Pharmaceuticals Inc | 1.03% | $76.84M |
| Erasca Inc | 1.03% | $76.58M |
| ACADIA Pharmaceuticals Inc | 1.02% | $75.97M |
| Sarepta Therapeutics Inc | 0.89% | $66.52M |
| Agios Pharmaceuticals Inc | 0.88% | $65.30M |
| Ultragenyx Pharmaceutical Inc | 0.88% | $65.11M |
| Disc Medicine Inc | 0.87% | $64.71M |
| Immunome Inc | 0.86% | $64.18M |
| Immunovant Inc | 0.86% | $63.75M |
| BioCryst Pharmaceuticals Inc | 0.85% | $63.36M |
| Veracyte Inc | 0.85% | $63.06M |
| Dyne Therapeutics Inc | 0.84% | $62.32M |
| Catalyst Pharmaceuticals Inc | 0.76% | $56.16M |
| Syndax Pharmaceuticals Inc | 0.74% | $54.74M |
| Denali Therapeutics Inc | 0.73% | $54.35M |
| Ideaya Biosciences Inc | 0.73% | $54.27M |
| Spyre Therapeutics Inc | 0.73% | $53.95M |
| GRAIL Inc | 0.72% | $53.81M |
| Viridian Therapeutics Inc | 0.70% | $52.17M |
| Recursion Pharmaceuticals Inc | 0.69% | $51.37M |
| Kodiak Sciences Inc | 0.69% | $51.24M |
| Soleno Therapeutics Inc | 0.67% | $50.09M |
| Dianthus Therapeutics Inc | 0.66% | $49.23M |
| Intellia Therapeutics Inc | 0.65% | $48.12M |
| Mineralys Therapeutics Inc | 0.65% | $48.04M |
| Arcus Biosciences Inc | 0.63% | $46.73M |
| Ardelyx Inc | 0.62% | $45.91M |
| ADMA Biologics Inc | 0.60% | $44.29M |
| Nurix Therapeutics Inc | 0.59% | $43.55M |
| Tango Therapeutics Inc | 0.56% | $41.27M |
| Celldex Therapeutics Inc | 0.52% | $38.78M |
| Novavax Inc | 0.51% | $38.00M |
| Oruka Therapeutics Inc | 0.50% | $37.33M |
| Olema Pharmaceuticals Inc | 0.50% | $36.86M |
| Stoke Therapeutics Inc | 0.49% | $36.65M |
| Vericel Corp | 0.48% | $35.91M |
| Capricor Therapeutics Inc | 0.48% | $35.63M |
| Palvella Therapeutics Inc | 0.46% | $34.18M |
| Biohaven Ltd | 0.44% | $32.53M |
| Monte Rosa Therapeutics Inc | 0.44% | $32.35M |
| Corvus Pharmaceuticals Inc | 0.42% | $30.97M |
| Iovance Biotherapeutics Inc | 0.38% | $28.57M |
| AnaptysBio Inc | 0.38% | $28.41M |
| Relay Therapeutics Inc | 0.38% | $28.17M |
| uniQure NV | 0.37% | $27.75M |
| ORIC Pharmaceuticals Inc | 0.37% | $27.51M |
| MannKind Corp | 0.36% | $26.79M |
| CareDx Inc | 0.35% | $25.70M |
| Taysha Gene Therapies Inc | 0.34% | $25.21M |
| Tyra Biosciences Inc | 0.34% | $25.10M |
| Geron Corp | 0.33% | $24.75M |
| Day One Biopharmaceuticals Inc | 0.32% | $23.87M |
| Precigen Inc | 0.31% | $23.24M |
| Vir Biotechnology Inc | 0.30% | $22.65M |
| KalVista Pharmaceuticals Inc | 0.29% | $21.70M |
| CytomX Therapeutics Inc | 0.29% | $21.20M |
| Annexon Inc | 0.28% | $21.18M |
| Kura Oncology Inc | 0.28% | $20.51M |
| Inhibrx Biosciences Inc | 0.27% | $19.94M |
| SELLAS Life Sciences Group Inc | 0.27% | $19.84M |
| Janux Therapeutics Inc | 0.27% | $19.80M |
| Compass Therapeutics Inc | 0.26% | $19.49M |
| Savara Inc | 0.26% | $19.41M |
| Rigel Pharmaceuticals Inc | 0.26% | $19.17M |
| Sana Biotechnology Inc | 0.26% | $19.15M |
| Cullinan Therapeutics Inc | 0.25% | $18.58M |
| ARS Pharmaceuticals Inc | 0.24% | $17.77M |
| Zenas Biopharma Inc | 0.24% | $17.72M |
| Xencor Inc | 0.23% | $17.15M |
| Replimune Group Inc | 0.23% | $16.82M |
| Sionna Therapeutics Inc | 0.22% | $16.70M |
| Vor BioPharma Inc | 0.22% | $16.63M |
| ArriVent Biopharma Inc | 0.22% | $16.17M |
| Ironwood Pharmaceuticals Inc | 0.19% | $14.04M |
| Bicara Therapeutics Inc | 0.19% | $13.96M |
| Prime Medicine Inc | 0.19% | $13.85M |
| Altimmune Inc | 0.18% | $13.41M |
| Absci Corp | 0.18% | $13.35M |
| Emergent BioSolutions Inc | 0.18% | $13.06M |
| Allogene Therapeutics Inc | 0.17% | $12.72M |
| Hyperliquid Strategies Inc | 0.17% | $12.48M |
| 4D Molecular Therapeutics Inc | 0.17% | $12.27M |
| Vanda Pharmaceuticals Inc | 0.16% | $11.77M |
| REGENXBIO Inc | 0.15% | $11.43M |
| Lexeo Therapeutics Inc | 0.14% | $10.69M |
| Verastem Inc | 0.14% | $10.68M |
| Arbutus Biopharma Corp | 0.14% | $10.21M |
| Myriad Genetics Inc | 0.13% | $9.72M |
| Prothena Corp PLC | 0.13% | $9.56M |
| Ocugen Inc | 0.13% | $9.45M |
| Rocket Pharmaceuticals Inc | 0.13% | $9.33M |
| MiMedx Group Inc | 0.12% | $9.02M |
| Akebia Therapeutics Inc | 0.11% | $8.39M |
| Anavex Life Sciences Corp | 0.11% | $8.15M |
| Contra Metsera, Inc. | 0.10% | $7.50M |
| Invivyd Inc | 0.10% | $7.35M |
| Perspective Therapeutics Inc | 0.10% | $7.15M |
| State Street Global Advisors | 0.06% | $4.70M |
| Damora Therapeutics Inc | 0.03% | $2.43M |
| Contra Akero Therapeut | 0.02% | $1.32M |
| Contra Inhibrx, Inc. | 0.01% | $1.07M |
| Contra Mirati Therapeu | 0.01% | $958.69K |
| Contra Verve Therapeut | 0.01% | $567.17K |
| Contra Blueprint Medic | 0.00% | $347.98K |
| State Street Global Advisors | 0.00% | $36.55K |
| Omniab, Inc. | 0.00% | $0 |
| Omniab, Inc. | 0.00% | $0 |